NDC 47426-201

CINVANTI

Aprepitant

CINVANTI is a Intravenous Injection, Emulsion in the Human Prescription Drug category. It is labeled and distributed by Heron Therapeutics, Inc.. The primary component is Aprepitant.

Product ID47426-201_53326a74-2dc8-4139-b514-9a61a340c69d
NDC47426-201
Product TypeHuman Prescription Drug
Proprietary NameCINVANTI
Generic NameAprepitant
Dosage FormInjection, Emulsion
Route of AdministrationINTRAVENOUS
Marketing Start Date2018-01-03
Marketing CategoryNDA / NDA
Application NumberNDA209296
Labeler NameHeron Therapeutics, Inc.
Substance NameAPREPITANT
Active Ingredient Strength130 mg/18mL
Pharm ClassesCytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 47426-201-01

1 VIAL, GLASS in 1 CARTON (47426-201-01) > 18 mL in 1 VIAL, GLASS
Marketing Start Date2018-01-03
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 47426-201-01 [47426020101]

CINVANTI INJECTION, EMULSION
Marketing CategoryNDA
Application NumberNDA209296
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2018-01-03

Drug Details

Active Ingredients

IngredientStrength
APREPITANT130 mg/18mL

OpenFDA Data

SPL SET ID:4c218d3a-a508-4abc-9ed8-a6e8e191d1b4
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1995155
  • 1995150
  • Pharmacological Class

    • Neurokinin 1 Antagonists [MoA]
    • Substance P/Neurokinin-1 Receptor Antagonist [EPC]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 2C9 Inducers [MoA]
    • Cytochrome P450 3A4 Inducers [MoA]

    NDC Crossover Matching brand name "CINVANTI" or generic name "Aprepitant"

    NDCBrand NameGeneric Name
    47426-201CINVANTICINVANTI
    0781-2321Aprepitantaprepitant
    0781-2322Aprepitantaprepitant
    0006-0461EMENDaprepitant
    0006-0462EMENDaprepitant
    0006-0464EMENDaprepitant
    0006-3066EMENDaprepitant
    0006-3862EMENDaprepitant

    Trademark Results [CINVANTI]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CINVANTI
    CINVANTI
    87101607 5419060 Live/Registered
    Heron Therapeutics, Inc.
    2016-07-12

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.